Skip to main content
SpringerLink
Log in

The insulin-like growth factors and breast cancer — revisited

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

In 1992, a special issue of Breast Cancer Research and Treatment was devoted to the insulin-like growth factors and breast cancer. In that issue, identification of the key components of the IGF system was reviewed and their potential role in breast cancer growth was described. In this issue, we revisit the IGF system with particular attention to data that further supports their role in the growth regulation of breast cancer. Several new facets of the IGF system are described, and several laboratories have more clearly defined how each individual component of the IGF system may influence breast cancer biology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Canobbio L, Cannata D, Miglietta L, Boccardo F: Somatuline (BIM 23014) and tamoxifen treatment of postmenopausal breast cancer patients: clinical activity and effect on insulin-like growth factor-I (IGF-I) levels. Anticancer Res 15:2687–2690, 1995

    Google Scholar 

  2. Szepeshazi K, Milovanovic S, Lapis K, Groot K, Schally AV: Growth inhibition of estrogen independent MXT mouse mammary carcinomas in mice treated with an agonist or antagonist of LH-RH, an analog of somatostatin, or a combination. Breast Cancer Res Treat 21:181–192, 1992

    Google Scholar 

  3. Arteaga CL, Kitten LJ, Coronado EB, Jacobs S, Kull FC Jr, Allred DC, Osborne CK: Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 84:1418–1423, 1989

    Google Scholar 

  4. Van Den Berg CL, Stroh C, Hilsenbeck SG, Weng C-N, McDermott MJ, Cox GN, Yee D: Polyethylene glycol conjugated insulin-like growth factor binding protein inhibits growth of breast cancer in athymic mice. Eur J Cancer 33:1108–1113, 1997

    Google Scholar 

  5. Belfiore A, Costantino A, Frasca F, Pandini G, Mineo R, Vigneri P, Maddux B, Goldfine ID, Vigneri R: Overexpression of membrane glycoprotein PC-1 in MDA-MB-231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity. Mol Endocrinol 10:1318–1326, 1996

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Texas Health Science Center, San Antonio, Texas, USA

    Douglas Yee

Authors
  1. Douglas Yee
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yee, D. The insulin-like growth factors and breast cancer — revisited. Breast Cancer Res Treat 47, 197–199 (1998). https://doi.org/10.1023/A:1005938615798

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005938615798

Search

Navigation